FLOT2 promotes nasopharyngeal carcinoma progression through suppression of TGF-β pathway via facilitating CD109 expression
Summary: In nasopharyngeal carcinoma (NPC), the TGF-β/Smad pathway genes are altered with inactive TGF-β signal, but the mechanisms remain unclear. RNA-sequencing results showed that FLOT2 negatively regulated the TGF-β signaling pathway via up-regulating CD109 expression. qRT-PCR, western blot, ChI...
Main Authors: | Hongjuan Xu, Yuze Yin, Yihan Li, Ning Shi, Wen Xie, Weiren Luo, Lei Wang, Bin Zhu, Weidong Liu, Xingjun Jiang, Caiping Ren |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-01-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004223026573 |
Similar Items
-
Implications of TGFβ on transcriptome and cellular biofunctions of palatal mesenchyme
by: Xiujuan eZhu, et al.
Published: (2012-04-01) -
Results of the observational prospective RealFLOT study
by: Elisa Giommoni, et al.
Published: (2021-10-01) -
TGFβ suppresses CD8+ T cell expression of CXCR3 and tumor trafficking
by: Andrew J. Gunderson, et al.
Published: (2020-04-01) -
Detection of a soluble form of CD109 in serum of CD109 transgenic and tumor xenografted mice.
by: Hiroki Sakakura, et al.
Published: (2014-01-01) -
Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma – the phase III “PREVENT”- (FLOT9) trial of the AIO /CAOGI /ACO
by: Thorsten O. Götze, et al.
Published: (2021-10-01)